Abstract
The Effect of Gabapentin Enacarbil (GEn) on Quality-of-Life (QoL) Outcomes in Adult Patients With Moderate-to-Severe and Severe Primary Restless Legs Syndrome (RLS): Pooled Analyses From Two 12-Week Trials (P7.299)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have